Promentis Pharmaceuticals Funding: $31M Raised, Series C
Promentis Pharmaceuticals is based in Milwaukee. It has raised $31M in total funding. Latest round: Series C.
Promentis Pharmaceuticals funding overview
Promentis Pharmaceuticals is based in Milwaukee. Promentis Pharmaceuticals has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2017. The round record for Promentis Pharmaceuticals runs through 2017; nothing later has been disclosed. Investors on record include OrbiMed, F-Prime Capital Partners, Aisling Capital, Black Pearl GmbH, Golden Angel Network. 5 distinct backers are named across the disclosed rounds.
Promentis Pharmaceuticals at a glance
Total raised
$31M
Latest round
Series C
Latest round date
March 2017
Headquarters
Milwaukee
Notable investors
OrbiMed, F-Prime Capital Partners, Aisling Capital, Black Pearl GmbH, Golden Angel Network
Frequently asked about Promentis Pharmaceuticals funding
How much has Promentis Pharmaceuticals raised?
Promentis Pharmaceuticals has raised $31M in total disclosed funding across the rounds on record.
Who has invested in Promentis Pharmaceuticals?
OrbiMed, F-Prime Capital Partners, Aisling Capital, Black Pearl GmbH, Golden Angel Network are named among the investors backing Promentis Pharmaceuticals.
What was the latest Promentis Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in March 2017.
Where is Promentis Pharmaceuticals based?
Promentis Pharmaceuticals is based in Milwaukee.
When did Promentis Pharmaceuticals last raise?
The last disclosed Promentis Pharmaceuticals round closed in March 2017 at Series C.
Promentis Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Milwaukee below to benchmark round size and investor mix.
Companies related to Promentis Pharmaceuticals (21)
